Asia-Pacific ADME Toxicology Testing Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Jul 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 99
  • No of Figures: 47

Asia-Pacific ADME Toxicology Testing Market, By Technology (Cell Culture, High Throughput, Molecular Imaging, Omics Technology), Product Type (Instruments, Assays and Reagents, Accessories, Software Solutions), Test (In-Vivo, In-Vitro), Method (Cellular Assay, Biochemical Assay, In-Silica, Ex-Vivo), Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Others), End User (Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institute, Others), Distribution Channel (Direct Tender, Others), Country (Japan, China , Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific) Industry and Forecast to 2028

Asia-Pacific ADME Toxicology Testing MarketMarket Analysis and Insights: Asia-Pacific ADME Toxicology Testing Market

Asia-Pacific ADME toxicology testing market is expected to gain substantial growth in the forecast period of 2021-2028. Data Bridge Market Research analyzes that the market is growing at a CAGR of 11.3% in the forecast period and is expected to reach USD 1,210.28 million by 2028. Increasing demand for toxicology testing products and rising investments in R&D by key market players are major drivers expected to propel the growth of the market in the forecast period.

ADME refers to the absorption, distribution, metabolism and elimination of drugs or chemicals in and from the body. ADME testing plays a vital role in the drug development process. The testing enables pharmaceutical companies to reduce their drug discovery time, cost, and test complications.

ADME is a critical piece in drug development studies, which helps determine the viability of a drug. Toxicology study is a crucial part of drug development used to characterize a drug's toxicity profile by identifying its impact on organ structure/ functionality. The study provides critical information and knowledge used by regulatory agencies to prevent or reduce the likelihood that a disease or other negative health outcome would occur. The food and Drug Administration has issued several guidance documents for industry such as safety testing of drug metabolites, In vitro metabolism and transporter-mediated drug-drug interaction studies, clinical drug interactions studies.

The ADME toxicology testing market is growing in the forecast year due to several reasons, such as the rising players in the market and availability of advanced products. Along with this, manufacturers are engaged in R&D activity for launching novel products in the market.

However, stringent rules and regulations of the government along with high cost of testing may hamper the ADME toxicology testing market growth in the forecast period.

The ADME toxicology testing market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific ADME Toxicology Testing MarketAsia-Pacific ADME Toxicology Testing Market Scope and Market Size

Asia-Pacific ADME toxicology testing market is segmented on the basis of technology, product type, test, method, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of technology, the Asia-Pacific ADME toxicology testing market is segmented into cell culture, high throughput, molecular imaging, and omics technology. The cell culture segment is expected to dominate the market in 2021 owing to increasing research and development activities along with technological advancements.
  • On the basis of product type, the Asia-Pacific ADME toxicology testing market is segmented into instruments, assays & reagents, accessories and software solutions. In 2021, assays & reagents segment is expected to dominate the Asia-Pacific ADME toxicology testing market due to increase in rate of late stage drug failure, and rise in need of novel drug molecules are predicted to dominate the market.
  • On the basis of test, the Asia-Pacific ADME toxicology testing market is segmented into in-vivo and in-vitro. In 2021, in-vitro segment is expected to dominate the Asia-Pacific ADME toxicology testing market due to surging levels of investment by the government and private organisations for the growth of the healthcare industry across the globe are predicted to dominate the market.
  • On the basis of method, the Asia-Pacific ADME toxicology testing market is segmented into cellular assay, biochemical assay, in-silica and ex-vivo. In 2021, cellular assay segment is expected to dominate the Asia-Pacific ADME toxicology testing market due to increase in rate of late stage drug failure and technological advancement.
  • On the basis of application, the Asia-Pacific ADME toxicology testing market is segmented into systemic toxicity, renal toxicity, hepato toxicity, neuro toxicity and others. In 2021, systemic toxicity segment is expected to dominate the Asia-Pacific ADME toxicology testing market due to an increase in awareness among the patients regarding the benefits of ADME toxicology testing.
  • On the basis of end user, the Asia-Pacific ADME toxicology testing market is segmented into biopharmaceutical companies, contract research organizations, academic and research institute and others. In 2021, biopharmaceutical companies segment is expected to dominate the Asia-Pacific ADME toxicology testing market due to the rise in the need of novel drug molecules for toxicology testing.
  • On the basis of distribution channel, the Asia-Pacific ADME toxicology testing market is segmented into direct tender and others. In 2021, the direct tender segment is expected to dominate the Asia-Pacific ADME toxicology testing market due to new recent developments, and trade regulations are predicted to dominate the market.

Asia-Pacific ADME Toxicology Testing MarketAsia-Pacific ADME toxicology testing Market Country Level Analysis

The ADME toxicology testing market is analyzed and market size information is provided on the basis of technology, product type, test, method, application, end user, and distribution channel.

Countries covered in the Asia-Pacific ADME toxicology testing market report are Japan, China, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, and Rest of Asia-Pacific.

The test segment in the Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2021-2028 owing to innovative R&D and new product launches and approvals. China is the fastest growing country in the Asia-Pacific ADME toxicology testing market because of a number of initiatives steps by the pharmaceutical as well as government authorities for innovative product manufacturing. Japan is expected to dominate the market due to rising players in the market and availability of advanced products. India is dominating rise in the need of novel drug molecules for toxicology testing.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points, such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges due to high competition from local and domestic brands and impact of sales channels are considered while providing forecast analysis of the country data.

Rise in Innovative R&D by Key Market Players and Technological Advancements are boosting the Market Growth of ADME toxicology testing.

Asia-Pacific ADME toxicology testing market also provides you with detailed market analysis for every country growth in ADME toxicology product industry with product sales, impact of advancement in the technology, and changes in regulatory scenarios with their support for the toxicology testing market. The data is available for historic period 2010 to 2019.

Competitive Landscape and ADME Toxicology Testing Market Share Analysis

The ADME toxicology testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the company’s focus related to Asia-Pacific ADME toxicology testing market.

The major companies which are dealing in the Asia-Pacific ADME toxicology testing market are Promega Corporation, Lonza, AAT Bioquest, Inc., Thermo Fisher Scientific Inc., Corning Incorporated, Charles River Laboratories, LABCYTE INC., BioIVT, Takara Bio Inc., Agilent Technologies, Inc., PromoCell GmbH, Merck KGaA, and Bio-Rad Laboratories, Inc., among others.

For instance,  

  • In May 2021, Merck KGaA, a leading science and technology company, announced the extension of its ongoing collaboration with BioMed X, Heidelberg, Germany. As a result of this successful collaboration, multiple innovative discovery projects in new research areas have been started at Merck.
  • In April 2021, Agilent Technologies Inc. announced that it has acquired Resolution Bioscience, which is a leader in the development and commercialization of Next Generation Sequencing based precision oncology solutions.

Customization Available: Asia-Pacific ADME Toxicology Testing Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 R&D COST BY KEY MARKET PLAYERS (USD MILLION) (2019-2020)

TABLE 2 ASIA-PACIFIC ADME TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 3 ASIA-PACIFIC ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 4 ASIA-PACIFIC ASSAYS AND REAGENTS IN ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE 2019-2028 (USD MILLION)

TABLE 5 ASIA-PACIFIC ADME TOXICOLOGY TESTING MARKET, BY TEST, 2019-2028 (USD MILLION)

TABLE 6 ASIA-PACIFIC ADME TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 7 ASIA-PACIFIC ADME TOXICOLOGY TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 8 ASIA-PACIFIC ADME TOXICOLOGY TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 9 ASIA-PACIFIC ADME TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 10 ASIA-PACIFIC ADME TOXICOLOGY TESTING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 11 CHINA ADME TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 12 CHINA ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 13 CHINA ASSAYS AND REAGENTS IN ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028(USD MILLION)

TABLE 14 CHINA ADME TOXICOLOGY TESTING MARKET, BY TEST, 2019-2028 (USD MILLION)

TABLE 15 CHINA ADME TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 16 CHINA ADME TOXICOLOGY TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 17 CHINA ADME TOXICOLOGY TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 18 CHINA ADME TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 19 JAPAN ADME TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 20 JAPAN ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 21 JAPAN ASSAYS AND REAGENTS IN ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 22 JAPAN ADME TOXICOLOGY TESTING MARKET, BY TEST, 2019-2028 (USD MILLION)

TABLE 23 JAPAN ADME TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 24 JAPAN ADME TOXICOLOGY TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 25 JAPAN ADME TOXICOLOGY TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 26 JAPAN ADME TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 27 INDIA ADME TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 28 INDIA ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 29 INDIA ASSAYA AND REAGENTS ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028(USD MILLION)

TABLE 30 INDIA ADME TOXICOLOGY TESTING MARKET, BY TEST, 2019-2028 (USD MILLION)

TABLE 31 INDIA ADME TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 32 INDIA ADME TOXICOLOGY TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 33 INDIA ADME TOXICOLOGY TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 34 INDIA ADME TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 35 SOUTH KOREA ADME TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 36 SOUTH KOREA ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 37 SOUTH KOREA ASSAYS AND REAGENTS IN ADME TOXICOLOGY TETSING MARKET, BY PRODUCT TYPE, 2019-2028(USD MILLION)

TABLE 38 SOUTH KOREA ADME TOXICOLOGY TESTING MARKET, BY TEST, 2019-2028 (USD MILLION)

TABLE 39 SOUTH KOREA ADME TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 40 SOUTH KOREA ADME TOXICOLOGY TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 41 SOUTH KOREA ADME TOXICOLOGY TETSING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 42 SOUTH KOREA ADME TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 43 AUSTRALIA ADME TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 44 AUTRALIA ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 45 AUSTRALIA ASSAYS AND REAGENTS IN ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028(USD MILLION)

TABLE 46 AUSTRALIA ADME TOXICOLOGY TESTING MARKET, BY TEST, 2019-2028 (USD MILLION)

TABLE 47 AUSTRALIA ADME TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 48 AUSTRALIA ADME TOXICOLOGY TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 49 AUSTRALIA ADME TOXICOLOGY TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 50 AUSTRALIA ADME TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 51 SINGAPORE ADME TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 52 SINGAPORE ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028(USD MILLION)

TABLE 53 SINGAPORE ASSAYS AND REAGENTS IN ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 54 SINGAPORE ADME TOXICOLOGY TESTING MARKET, BY TEST, 2019-2028 (USD MILLION)

TABLE 55 SINGAPORE ADME TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 56 SINGAPORE ADME TOXICOLOGY TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 57 SINGAPORE ADME TOXICOLOGY TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 58 SINGAPORE ADME TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 59 THAILAND ADME TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 60 THAILAND ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028(USD MILLION)

TABLE 61 THAILAND ASSAYS AND REAGENTS IN ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 62 THAILAND ADME TOXICOLOGY TESTING MARKET, BY TEST, 2019-2028 (USD MILLION)

TABLE 63 THAILAND ADME TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 64 THAILAND ADME TOXICOLOGY TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 65 THAILAND ADME TOXICOLOGY TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 66 THAILAND ADME TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 67 MALAYSIA ADME TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 68 MALAYSIA ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028(USD MILLION)

TABLE 69 MALAYSIA ASSAYS AND REAGENTS IN ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 70 MALAYSIA ADME TOXICOLOGY TESTING MARKET, BY TEST, 2019-2028 (USD MILLION)

TABLE 71 MALAYSIA ADME TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 72 MALAYSIA ADME TOXICOLOGY TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 73 MALAYSIA ADME TOXICOLOGY TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 74 MALAYSIA ADME TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 75 INDONESIA ADME TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 76 INDONESIA ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028(USD MILLION)

TABLE 77 INDONESIA ASSAYS AND REAGENTS IN ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 78 INDONESIA ADME TOXICOLOGY TESTING MARKET, BY TEST, 2019-2028 (USD MILLION)

TABLE 79 INDONESIA ADME TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 80 INDONESIA ADME TOXICOLOGY TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 81 INDONESIA ADME TOXICOLOGY TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 82 INDONESIA ADME TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 83 PHILIPPINES ADME TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 84 PHILIPPINES ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 85 PHILIPPINES ASSAYS AND REAGENTS IN ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 86 PHILIPPINES ADME TOXICOLOGY TESTING MARKET, BY TEST, 2019-2028 (USD MILLION)

TABLE 87 PHILIPPINES ADME TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 88 PHILIPPINES ADME TOXICOLOGY TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 89 PHILIPPINES ADME TOXICOLOGY TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 90 PHILIPPINES ADME TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 91 VIETNAM ADME TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 92 VIETNAM ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 93 VIETNAM ASSAYS AND REAGENTS IN ADME TOXICOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 94 VIETNAM ADME TOXICOLOGY TESTING MARKET, BY TEST, 2019-2028 (USD MILLION)

TABLE 95 VIETNAM ADME TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2028 (USD MILLION)

TABLE 96 VIETNAM ADME TOXICOLOGY TESTING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 97 VIETNAM ADME TOXICOLOGY TESTING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 98 VIETNAM ADME TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 99 REST OF ASIA-PACIFIC ADME TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions